Cost-effectiveness of Multidisciplinary Interventions for Chronic Low Back Pain

Abstract

Objective: Chronic musculoskeletal pain in adults is a global health and economic problem. The aim of this paper was to systematically review and determine what proportion of multidisciplinary approaches to managing chronic musculoskeletal pain are cost-effective. Materials and Methods: The EconLit, Embase, and PubMed electronic databases were searched for randomized and nonrandomized economic evaluation studies of nonpharmaceutical multidisciplinary chronic pain management interventions published from inception through to August 2019. Results: Seven studies comprising 2095 patients were included. All studies involved diverse multidisciplinary teams in one or more of the study arms. All studies involved chronic (both chronic and subacute) low back pain and were economic evaluations from either a societal or health care perspective. Two of the 3 studies that reported on a multidisciplinary pain intervention compared with nonmultidisciplinary intervention concluded favorable cost-effectiveness based on cost per quality adjusted life years gained, 1 study was not found to be cost-effective. Cost-effectiveness of the multidisciplinary intervention of interest was also not established by another 3-arm study. Two studies compared 2 multidisciplinary interventions; neither of these could definitively declare cost-effectiveness. The remaining study indicated the intervention by a multidisciplinary team was more effective but at a higher cost. None of the included studies used decision models to estimate long-term health outcomes and cost-effectiveness of multidisciplinary programs. Discussion: There are few studies on the cost-effectiveness of multidisciplinary chronic pain management interventions. This study encourages additional rigorous economic evaluations of multidisciplinary models for chronic pain management. Economic evaluations that enable extrapolating costs and effects of multidisciplinary programs beyond the time horizon of clinical trials may be more informative for clinicians and health administrators.

The invisible cost of pain management by the current International Classification of Diseases coding system: a study in a tertiary care inpatient setting

“…Despite the evidence that adequate pain management can save costs in an inpatient setting, 2,5 these data show that all government hospitals in Thailand who are refunded based on the ICD-10 coding system cannot receive any reimbursement for managing pain conditions. We propose that this is the case in many hospitals worldwide.…”

Economic analysis of patient-related effects of an interdisciplinary pain self-management program

“…Labor force participation is an important indicator beyond improved health outcomes of tax paid after RTW, less dependence on welfare payments, and less dependence on family members for financial support. 12 Our study also has a number of limitations. First, although our analyses controlled for important known baseline differences for ADAPT patients, other unknown or unmeasured confounders could have contributed to our findings.…”

“…Many patients gradually resume activities of normal life, despite persisting pain, after participating in such intensive pain management programs. 22,23,35 A systematic literature review of the cost-effectiveness of multidisciplinary pain management programs 12 suggested that although relatively few studies have examined this issue, some have reported favourable cost-effectiveness outcomes. 28,29 The reviewed studies encouraged additional rigorous economic analysis of such interdisciplinary pain management programs.…”

Multidisciplinary amyloidosis care in the era of personalized medicine

“…Multi-disciplinary care is now considered the gold standard in the care of complex diseases, particularly in our current era of personalized medicine. The value and cost-effectiveness of multidisciplinary care spans numerous disorders, ranging from chronic kidney disease ( 42 ) to congestive heart failure ( 43 ) to amyotrophic lateral sclerosis ( 44 ). For example, multidisciplinary care improves mortality in ALS patients ( 45 ).…”